The IC-8 IOL uses the small-aperture concept to extend cataract patients’ depth of focus. Patients report high approval and reduced spectacle dependence.
Community support is the most important factor in ascertaining effective treatments for paediatric eye diseases.
Enhancing cataract surgery with advanced optics
Understanding vitreomacular interface diseases is key to treatment.
With investigations into CVI in the early phases, collaboration across the Atlantic is crucial
As OCT-A devices become faster, the algorithms advance and the instrument costs decrease, more widespread utilisation in retina practices is likely.
Key takeaways from a discussion on the management of age-related macular degeneration, diabetic macular edema, and inherited retinal disease and insight regarding what to look forward to as the field advances.
A case report demonstrates independent effect of GLP-1 receptor agonist
Early detection and diagnosis are key for these young patients
Astigmatic values differed between K and TK readings
Patients desire spectacle independence at all distances. Early experience with a recently launched IOL suggests that it can satisfy their demands for extended depth of vision.
Minimally invasive glaucoma surgery (MIGS) is appealing to glaucoma patients and surgeons; however, it should not be adopted without further high-quality research and careful reporting. Selection of the appropriate treatment for individual patients must be evidence based.
Corneal aberrations may occur more frequently than is generally appreciated, and they affect the visual outcomes following cataract surgery. Small-aperture optics provide a solution for a large category of patients who are otherwise not well served by complex IOLs.
Strategies for the management and prevention of floppy iris syndrome include intraoperative interventions and recommendations on alternatives to tamsulosin for medical therapy in men with cataracts.
Investigators found that a fluocinolone acetonide implant maintained good real-world vision levels in patients with diabetic macular oedema who had good baseline vision.
OWL's ESCRS 2023 event on Sunday, September 10, at 7 pm, promises an evening of visionary leadership and collaboration in ophthalmic innovation.
SD-OCT is providing reproducible, high-quality, registered images to assess the treatment response in macular disease.
Need for accuracy results in optimisation of training for novice surgeons
Underlying autoimmune disease alters uveitis therapy.
Minimally invasive glaucoma surgery (MIGS) is appealing to glaucoma patients and surgeons; however, it should not be adopted without further high-quality research and careful reporting. Selection of the appropriate treatment for individual patients must be evidence based.
An interdisciplinary team at Duke University has developed a proof-of-concept machine learning model capable of detecting symptomatic Alzheimer disease using multimodal retinal imaging data.
Although the majority of patients experience benefit with brolucizumab for the treatment of nAMD without severe adverse events, the risk of retinal vasculitis and/or retinal vascular occlusion needs to be balanced with potential benefits.
SS-OCT provides a clear view of the eye’s internal structures and any abnormalities, helping to differentiate benign from malignant lesions.
Investigators found that ab-interno implantation of a supraciliary allograft bio-tissue successfully reduced intraocular pressure with comparable safety to other minimally invasive glaucoma surgical procedures
Growing evidence supports dual therapy to slow progression.
A global survey of retinal experts assessed their perceptions of evolving clinical practice in the Covid-19 era, focusing on digital teleophthalmology, home monitoring and decentralised patient care.
Compounded medications are playing a central role in the process.
A look at how EDOF technology can be categorised into five types